Cadrenal Therapeutics, Inc.(CVKD)
$1.510.00 (0.00%)
CVKD
Cadrenal Therapeutics, Inc. financials statements
$1.51
At close:0.00 (0.00%)
Want to see CVKD full AI Analyst Report?
Cadrenal Therapeutics, Inc. (CVKD) Income Statement
450 Followers
Cadrenal Therapeutics, Inc. Income Statement
Last quarter (Q2 2026), Cadrenal Therapeutics, Inc.'s total revenue was $0.00. In Q2, Cadrenal Therapeutics, Inc.'s net income was $-3.32M. See Cadrenal Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Mar 26 | Dec 24 | Dec 23 | Dec 22 |
|---|---|---|---|---|
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 0.00 | $ -1.88K | $ 0.00 | $ -1.27K | |
| $ 13.46M | $ 10.96M | $ 7.63M | $ 2.70M | |
| Depreciation and Amortization | $ 6.87K | $ 1.88K | $ 1.98K | $ 1.27K |
| $ -13.23M | $ -10.65M | $ -8.34M | $ -6.61M | |
| $ -13.46M | $ -10.96M | $ -7.63M | $ -2.70M | |
| $ 223.81K | $ 309.25K | $ -724.24K | $ -4.01M | |
| $ -13.24M | $ -10.65M | $ -8.36M | $ -6.71M | |
| $ -13.24M | $ -10.65M | $ -8.36M | $ -6.71M | |
| Per Share Metrics | ||||
| Basic EPS | $ -6.64 | $ -8.73 | $ -9.63 | $ -8.66 |
| Diluted EPS | $ -6.64 | $ -8.73 | $ -9.63 | $ -8.66 |
| Weighted Average Shares Outstanding | 1.99M | 1.22M | 868.18K | 775.64K |
| Weighted Average Shares Outstanding (Diluted) | 1.99M | 1.22M | 868.18K | 775.64K |
Currency in USD
